Tamoxifen vaginal (Pear Tree Pharmaceuticals)

N/A

Report date: 2023/12/08 16:06:49

Base Information

Drug NameTamoxifen vaginal (Pear Tree Pharmaceuticals)
Drug Alias NameDARE-VVA1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsVulvar and vaginal atrophyAtrophic VaginitisVaginitis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesDaré Bioscience Inc
Inactive CompaniesDare Bioscience Inc
Active IndicationsVulvar and vaginal atrophyAtrophic VaginitisDyspareunia
Inactive IndicationsVaginitis

Other Information

ATC CodeN/A
Related LinksN/A